To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.

Bill HR 5382 is currently in the status of Bill Introduced since December 10, 2019. Bill HR 5382 was introduced during Congress 116 and was introduced to the House on December 10, 2019.  Bill HR 5382's most recent activity was Referred to the Subcommittee on Health. as of December 11, 2019